Soumit Roy
Stock Analyst at Jones Trading
(0.01)
# 3,795
Out of 4,829 analysts
37
Total ratings
12.5%
Success rate
-51.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MURA Mural Oncology | Downgrades: Hold | n/a | $2.63 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $8.75 | +71.43% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $2.14 | +368.38% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $18.34 | +85.39% | 2 | Mar 10, 2025 | |
| INAB IN8bio | Upgrades: Buy | $1.2 | $0.16 | +654.72% | 4 | Feb 11, 2025 | |
| OKUR OnKure Therapeutics | Initiates: Buy | $32 | $1.93 | +1,558.03% | 1 | Jan 28, 2025 | |
| EPIX ESSA Pharma | Downgrades: Hold | n/a | $1.70 | - | 1 | Nov 1, 2024 | |
| ELTX Elicio Therapeutics | Initiates: Buy | $9 | $5.43 | +65.75% | 1 | Oct 31, 2024 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $36 | $19.42 | +85.42% | 1 | Oct 31, 2024 | |
| ORIC ORIC Pharmaceuticals | Initiates: Buy | $17 | $5.42 | +213.94% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.50 | +766.67% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.69 | +476.78% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.84 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.36 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $7.94 | +227.46% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $26.18 | +167.38% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $34.00 | -70.59% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $1.24 | +1,996.77% | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.53 | +1,598.75% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.74 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $9.93 | +705.64% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.15 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $5.20 | +6,053.85% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $5.24 | +15,358.02% | 1 | Feb 24, 2021 |
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.63
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $8.75
Upside: +71.43%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $2.14
Upside: +368.38%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $18.34
Upside: +85.39%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $1.2
Current: $0.16
Upside: +654.72%
OnKure Therapeutics
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $1.93
Upside: +1,558.03%
ESSA Pharma
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.70
Upside: -
Elicio Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $5.43
Upside: +65.75%
Enliven Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $36
Current: $19.42
Upside: +85.42%
ORIC Pharmaceuticals
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $5.42
Upside: +213.94%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.50
Upside: +766.67%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.69
Upside: +476.78%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.84
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.36
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $7.94
Upside: +227.46%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $26.18
Upside: +167.38%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $34.00
Upside: -70.59%
Aug 18, 2023
Initiates: Buy
Price Target: $26
Current: $1.24
Upside: +1,996.77%
May 24, 2023
Initiates: Buy
Price Target: $9
Current: $0.53
Upside: +1,598.75%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $8.74
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $9.93
Upside: +705.64%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.15
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $5.20
Upside: +6,053.85%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $5.24
Upside: +15,358.02%